Opioid Companies Reach Tentative $161.5 Million Settlement in West Virginia
The lawsuit accused the defendants of downplaying the risks of addiction associated with opioid use while overstating the benefits.
Attorneys for the state of West Virginia and pharmaceutical manufacturers Teva Pharmaceuticals Inc., AbbVie’s Allergan, and their family of companies have reached a tentative $161.5 million settlement, reports the Associated Press. The lawsuit accused the defendants of downplaying the risks of addiction associated with opioid use while overstating the benefits.
Under the deal, West Virginia would receive more than $134.5 million in cash, while Teva would supply the state with $27 million worth of Narcan. In addition, 72.5 percent of the settlement will go to a nonprofit foundation established to distribute money in opioid-related litigations, 24.5 percent will be allocated to local governments, and 3 percent will go to the state. The foundation would consist of an 11-member board, including five state appointees and representatives from six state regions. The board members will have expertise in mental health, substance misuse and law enforcement.